CLPT · ClearPoint Neuro, Inc.
Market Cap
$460.00M
Shares
30.50M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$14.90
Open$15.11
Day$14.46–15.30
52W close$8.66–29.60
Avg vol 30d604K
Short int4.5M · 14.7% float · 5.9d
Short vol56%
Last earningsAug 3, 2026
DataJan 2020–Sep 2026
Filing10-Q · Aug 3
Up next
Next earnings call
Oct 26, 2026
Est · unconfirmed
· in 8 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 3, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.3 · calm
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+11%
above
Price vs 50-day avg
−6%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
30%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+16%
trailing
6-month return
+28%
trailing
YTD return
+9%
this year
Relative strength
+16%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $16 › 200d $13 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +21 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
14.74% of float · ▲ +15.5% MoM · 5.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
130 holders — near 3-yr high, broad support
Squeeze score
73
high risk · 0–100
Fundamentals
Revenue growth
+18%
Y/Y
Gross margin
61%
expanding
EPS growth
−29%
Y/Y
Free cash flow
$-24.4M
Balance sheet
$3.2M
net debt
Quant / Vol
risk profile
Volatility
106%
annualized · 1-yr
Max drawdown
−71%
past year
ATR
5.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+11%
Bullish
Price vs 50-day avg
−6%
Bearish
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
30%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $16 › 200d $13 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +21 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
14.74% of float · ▲ +15.5% MoM · 5.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
130 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $9
Now $15 · 30%
Range high $30
vs 200-day avg +11%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CLPT
this stock
ClearPoint Neuro, Inc.
|
$460.00M | +8.9% | +17.8% | — | 14.7% |
|
ABT
Abbott Laboratories
|
$191.81B | -13.1% | +5.7% | 30.9 | 1.2% |
|
SYK
Stryker Corp
|
$126.84B | -9.7% | +11.2% | 34.3 | 1.8% |
|
MDT
Medtronic plc
|
$117.82B | -4.2% | +8.4% | 24.7 | 1.1% |
|
BSX
Boston Scientific Corp
|
$70.00B | -49.6% | +12.5% | 19.6 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CLPT | -12.2% | +15.7% | +28.2% | -1.6% | +8.9% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | -11.6% | +16.9% | +15.6% | -0.9% | -2.8% |
Key facts
CIK
1285550
CUSIP
18507C103
13F (30d)
108 filings
107 filers
Visit website
Investor relations